NYSE | ETF
The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents.
The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 7.32% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 6.97% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 6.12% |
| CELC | Celcuity LLC | Healthcare | Biotechnology | 5.86% |
| ACLX | Arcellx Inc | Healthcare | Biotechnology | 5.36% |
| IPN | Ipsen SA | Healthcare | Drug Manufacturers - Specialty & Generic | 4.73% |
| TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 4.73% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 4.51% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 4.43% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 4.21% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 4.20% |
| SWTX | SpringWorks Therapeutics Inc | Healthcare | Biotechnology | 4.04% |
| 6160 | BeOne Medicines AG | Healthcare | Biotechnology | 4.04% |
| 4502 | Takeda Pharmaceutical Co. Ltd. | Healthcare | Drug Manufacturers - Specialty & Generic | 3.99% |
| BAYN | Bayer AG NA | Healthcare | Drug Manufacturers - General | 3.99% |
| ROP | Roche Holding AG | Healthcare | Drug Manufacturers - General | 3.99% |
| GSK | GSK plc | Healthcare | Drug Manufacturers - General | 3.97% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 3.87% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 3.70% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 3.63% |